Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)
The Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is expected to reach US$ 1,870.3 million by 2028 from US$ 816.0 million in 2021; it is estimated to grow at a CAGR of 12.6% from 2021 to 2028.
In-silico clinical trials can supplement phase II drug trials to explore the safety and efficacy in the more infrequent phenotypes that usually appear only in phase III and predict the dose-effect relationship. Computational study in natural drug discovery is used to determine the metabolic pathways of active molecules and find the new targets and new molecules with high affinity to those targets. For instance, camptothecin derivatives (monoterpene-indole alkaloids) have been clinically employed as antitumor drugs. Such studies may explain how an in-silico metabolic analysis can improve the experimental decorations to gain more comprehensible biological information. Another aspect of human trials is that they are expensive, lengthy, and are typically designed with a narrow scope. But in-silico trials can be designed to answer a wide variety of relevant questions by providing sufficient statistical power to test the different hypotheses with a relatively small increase in resources associated with evaluating more models once the computational machinery is developed and implemented.
Furthermore, unlike conventional clinical trials, in-silico clinical trials are readily approved and authorized by the food and drug administration (FDA). Incrementally but inevitably, the in-silico clinical trial approach is expected to become the most significant evidence for regulatory evaluations. These factors indicate that the benefits mentioned above are substantially driving the in-silico trial market in Europe.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market at a promising CAGR during the forecast period.
Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
The market for in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into organization size, offerings, application, clinical indication, and end user. Based on organization size, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into small and medium organizations and large organizations. Based on offerings, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into products, platforms, and services. Based on application, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into product design and discovery, product development, pre-clinical targeting, assessment of drugs and other biomedical products, and others. Based on clinical indication, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into cardiovascular diseases, neurodegenerative diseases, oncology, rare diseases, metabolic diseases, immune based diseases, infectious diseases, and others. Based on end user, the in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into pharmaceutical and biopharmaceutical companies, medical technology companies, contract research organizations, and others. By country, the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into Germany, the UK, France, Spain, Italy, and the rest of Europe.
InSilicoTrials Technologies; Feops; CADFEM Medical GmbH; Dassault Systèmes SE; Virtonomy GmbH; Certara Inc.; Computational Life; NOVA; TwInsight Medical; Ansys, Inc.; Synopsys, Inc.; Sensyne Health plc.; and Cerner Corporation are among the leading companies in the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.2.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Organization Size
1.2.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Offering
1.2.3 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Application
1.2.4 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Clinical Indication
1.2.5 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By End User
1.2.6 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. In-Silico Trial Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Concerns Over Animal Welfare and Benefits
5.1.2 Insufficient Variable Patient Data and Limited Timescale
5.2 Market Restraints
5.2.1 Insufficient Variable Patient Data and Limited Timescale
5.3 Market Opportunities
5.3.1 Growing Applications of In-silico Trials in Radiology and Orthopedic Device Industry
5.4 Future Trends
5.4.1 Adoption of Artificial Intelligence in In-Silico Drug Discovery
5.5 Impact Analysis
6. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Europe Analysis
6.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue Forecast and Analysis
7. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028– by Organization Size
7.1 Overview
7.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, By Organization Size, 2020 & 2028 (%)
7.3 Large Organizations
7.3.1 Overview
7.3.2 Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Small and Medium Organizations
7.4.1 Overview
7.4.2 Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
8. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Offering
8.1 Overview
8.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
8.3 Products
8.3.1 Overview
8.3.2 Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
8.4 Platforms
8.4.1 Overview
8.4.2 Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Application
9.1 Overview
9.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
9.3 Product Design and Discovery
9.3.1 Overview
9.3.2 Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.4 Product Development
9.4.1 Overview
9.4.2 Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.5 Pre-Clinical Targeting
9.5.1 Overview
9.5.2 Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.6 Assessment of Drugs and Other Biomedical Products
9.6.1 Overview
9.6.2 Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others (Optimization and Market Access)
9.7.1 Overview
9.7.2 Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Clinical Indication
10.1 Overview
10.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
10.3 Cardiovascular Disease
10.3.1 Overview
10.3.2 Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.4 Neurodegenerative Disease
10.4.1 Overview
10.4.2 Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.5 Oncology
10.5.1 Overview
10.5.2 Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.6 Rare Diseases
10.6.1 Overview
10.6.2 Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.7 Metabolic Diseases
10.7.1 Overview
10.7.2 Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.8 Immune Based Diseases
10.8.1 Overview
10.8.2 Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.9 Infectious Diseases
10.9.1 Overview
10.9.2 Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.10 Others (Haematology, Diabetes, Dermatology)
10.10.1 Overview
10.10.2 Others (Haematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – End User
11.1 Overview
11.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.4 Medical Technology Companies
11.4.1 Overview
11.4.2 Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.6 Others (Universities and Research Centres)
11.6.1 Overview
11.6.2 Others (Universities and Research Centres): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
12. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
12.1.1 Overview
12.1.2 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.4 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.4.1 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.4.2 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.4.3 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5 Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)
12.1.5.1 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.1 Overview
12.1.5.1.2 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.3 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.4 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.5 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.6 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.1.7 Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.1 Overview
12.1.5.2.2 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.3 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.4 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.5 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.6 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.2.7 France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.1 Overview
12.1.5.3.2 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.3 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.4 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.5 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.6 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.3.7 UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.1 Overview
12.1.5.4.2 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.3 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.4 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.5 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.6 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.4.7 Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.1 Overview
12.1.5.5.2 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.3 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.4 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.5 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.6 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.5.7 Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.1 Overview
12.1.5.6.2 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.3 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.4 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.5 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.6 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.5.6.7 Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
13. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 InSilicoTrials Technologies
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 FEops
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 CADFEM Medical GmbH
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dassault Systèmes SE
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Virtonomy GmbH
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Certara Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Computational Life
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Novadiscovery
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TwInsight Medical
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Ansys, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Synopsys, Inc.
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Sensyne Health plc.
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Cerner Corporation
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 2. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 13. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 36. Organic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Table 37. Inorganic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Table 38. Glossary of Terms
LIST OF FIGURES
Figure 1. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation
Figure 2. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview
Figure 3. Large Organizations Segment Held Largest Share of Organization Size Segment in In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, Industry Landscape
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. In-Silico Trial Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2020 & 2028 (%)
Figure 11. Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 14. Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 15. Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 16. Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 18. Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 24. Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Others (Hematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 33. Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Others (Universities and Research Centers): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Key Country – Revenue (2021) (US$ Million)
Figure 38. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)
Figure 40. Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)
- InSilicoTrials Technologies
- Feops
- CADFEM Medical GmbH
- Dassault Systèmes SE
- Virtonomy GmbH
- Certara Inc.
- Computational Life
- NOVA
- TwInsight Medical
- Ansys, Inc.
- Synopsys, Inc.
- Sensyne Health plc.
- Cerner Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.